Striving for Equity: Examining Health Disparities in Urologic Oncology

Cancers (Basel). 2024 Oct 22;16(21):3559. doi: 10.3390/cancers16213559.

Abstract

Health disparities in urologic oncology, particularly in prostate, bladder, kidney, and testicular cancers, significantly impact patient outcomes across different demographic groups. This narrative review aims to investigate the extent and drivers of these disparities, focusing on the influence of race, socioeconomic status, and geographic location on diagnosis, treatment, and survival outcomes. We conducted a comprehensive review of the existing literature and analyzed data from national cancer databases to identify patterns of inequity. Our findings reveal that minority populations, individuals with lower socioeconomic status, and those residing in underserved areas are less likely to receive timely and guideline-based care, leading to worse outcomes. This review underscores the urgent need for targeted interventions, including policy reforms, health system restructuring, enhanced community outreach, and increased funding for disparity-focused research, to ensure equitable access to high-quality oncologic care. Addressing these disparities is crucial for improving cancer outcomes and achieving health equity in urologic oncology.

Keywords: bladder cancer; cancer treatment equity; clinical decision making; health disparities; prostate cancer; racial disparities; socioeconomic status; urologic oncology.

Publication types

  • Review

Grants and funding

This research received no external funding.